All Stories

  1. Parvovirus-B19-Infektionen
  2. Sexuell übertragbare Infektionen
  3. Paediatric invasive group A streptococcal infections and associations with viral infections in 15 European countries after lifting non-pharmaceutical interventions against SARS-CoV-2: an interrupted time-series analysis
  4. Natural History of Swiss Infants with Non-SCID T-cell Lymphopenia Detected by Newborn Screening: A Cohort Study
  5. Impact of SARS-CoV-2 Pandemic on Pediatric Inpatients with Invasive Group A Streptococcal Infections (iGAS): Results of a National Survey
  6. Untargeted Metabolite Profile Associations With Body Mass Index, Waist–Hip Ratio, and Antiretroviral Therapy in >1300 People With HIV: The Swiss HIV Cohort Study
  7. Association of SARS-CoV-2 vaccination status with risk of influenza-like illness and loss of workdays in healthcare workers
  8. Leukocyte count and new‐onset diabetes mellitus in people with HIV: A longitudinal study
  9. Research gaps for children who are HIV-exposed but uninfected: outcomes of a research prioritisation workshop
  10. Low Trauma Fractures in People With HIV: Longitudinal Time Trends in the Swiss HIV Cohort Study, 2009–2022
  11. Diet Diversity and Adherence to a Mediterranean Diet Pattern in Pregnancy Is Protective Against the Development of Early-Childhood Atopic Dermatitis
  12. Mycobacterium tuberculosis Infection and Acute or Subclinical Coronary Artery Disease: the Swiss HIV Cohort Study
  13. Types of Myocardial Infarction in People With HIV in Switzerland
  14. Dynamic of Pediatric Invasive Bacterial Infections in Switzerland: A 2017–2024 Time-series Analysis of National Data
  15. Outcomes After Prenatal Exposure to Raltegravir-Containing Antiretroviral Therapy: A Multicohort European Study
  16. Serotype epidemiology and case-fatality risk of invasive pneumococcal disease: a nationwide population study from Switzerland, 2012–2022
  17. Evaluation of self-collected dried blood spots for detection of SARS-CoV-2 nucleocapsid antibodies shows low sensitivity
  18. Fluorescent Probe for the pH-Independent Rapid and Sensitive Direct Detection of Urease-Producing Bacteria
  19. Burden of post–acute COVID-19 sequelae in healthcare workers and its course over a 30-month period–results from a prospective multicentre cohort
  20. Colonization with resistant bacteria in hospital employees: an epidemiological surveillance and typing study
  21. Syphilis in pregnant women and congenital syphilis from 2012 to 2021 in Switzerland: a multicentre, retrospective study
  22. HIV postnatal prophylaxis and infant feeding policies vary across Europe: results of a Penta survey
  23. Cohort profile: the Swiss Mother and Child HIV Cohort Study (MoCHiV)
  24. Evaluation of Psychosomatic, Respiratory, and Neurocognitive Health in COVID-19 Survivors 12 Months after ICU Discharge
  25. Socioeconomic Status and Adherence to Preventive Measures During the COVID-19 Pandemic in Switzerland: A Population Based Digital Cohort Analysis
  26. SARS‐CoV‐2 Vaccination is Not Associated With Involuntary Childlessness in Female Healthcare Workers: A Multicenter Cohort Study
  27. Clinical Characteristics and Management of Children and Adolescents Hospitalized With Pyomyositis
  28. Trends in preterm birth in women living with HIV in Switzerland over the last three decades: A multicentric, prospective, cohort study
  29. SARS-CoV-2 immunity and reasons for non-vaccination among healthcare workers from eastern and northern Switzerland: results from a nested multicentre cross-sectional study
  30. Long-term trajectories of densely reported depressive symptoms during an extended period of the COVID-19 pandemic in Switzerland: Social worries matter
  31. Impact of shift work and other work-related factors on anti-SARS-CoV-2 spike-protein serum concentrations in healthcare workers after primary mRNA vaccination – a retrospective cohort study
  32. S-Gene Target Failure as an Effective Tool for Tracking the Emergence of Dominant SARS-CoV-2 Variants in Switzerland and Liechtenstein, Including Alpha, Delta, and Omicron BA.1, BA.2, and BA.4/BA.5
  33. Evolution of symptoms compatible with post-acute sequelae of SARS-CoV-2 (PASC) after Wild-type and/or Omicron BA.1 infection: A prospective healthcare worker cohort
  34. Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients
  35. Organ Dysfunction in Children With Blood Culture-Proven Sepsis: Comparative Performance of Four Scores in a National Cohort Study
  36. Association between perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in paediatric uncomplicated appendectomy: a Swiss retrospective cohort study
  37. Interplay of Digital Proximity App Use and SARS-CoV-2 Vaccine Uptake in Switzerland: Analysis of Two Population-Based Cohort Studies
  38. SARS-CoV-2 risk in household contacts of healthcare workers: a prospective cohort study
  39. Viral suppression and retention in HIV care during the postpartum period among women living with HIV: a longitudinal multicenter cohort study
  40. Development of hybrid immunity during a period of high incidence of Omicron infections
  41. Humoral and cellular BNT162b2 mRNA-based booster vaccine-induced immunity in patients with multiple myeloma and persistence of neutralising antibodies: results of a prospective single-centre cohort study
  42. Sensitivity of ICD coding for sepsis in children—a population-based study
  43. Clinical symptoms of SARS‐CoV‐2 breakthrough infection during the Omicron period in relation to baseline immune status and booster vaccination—A prospective multicentre cohort of health professionals (SURPRISE study)
  44. Migrating a Well-Established Longitudinal Cohort Database From Oracle SQL to Research Electronic Data Entry (REDCap): Data Management Research and Design Study
  45. Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study
  46. Reply to Zeng and Zhou
  47. Successful implementation of new Swiss recommendations on breastfeeding of infants born to women living with HIV
  48. Changes in socioeconomic resources and mental health after the second COVID-19 wave (2020–2021): a longitudinal study in Switzerland
  49. Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study
  50. Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study
  51. The quorum sensing com system regulates pneumococcal colonisation and invasive disease in a pseudo-stratified airway tissue model
  52. Maternal and perinatal outcomes following pre-Delta, Delta, and Omicron SARS-CoV-2 variants infection among unvaccinated pregnant women in France and Switzerland: a prospective cohort study using the COVI-PREG registry
  53. Detection of mostly viral pathogens and high proportion of antibiotic treatment initiation in hospitalised children with community-acquired pneumonia in Switzerland – baseline findings from the first two years of the KIDS-STEP trial
  54. Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19
  55. Outbreak investigation including molecular characterization of community associated methicillin-resistant Staphylococcus aureus in a primary and secondary school in Eastern Switzerland
  56. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland—A multicentre cohort study
  57. Implementation of an electronic, secure, web-based application to support routine hand hygiene observation with immediate direct feedback and anonymized benchmarking
  58. Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatment
  59. Transfer of antiretroviral drugs into breastmilk: a prospective study from the Swiss Mother and Child HIV Cohort Study
  60. Swiss recommendations on perioperative antimicrobial prophylaxis in children
  61. Lifestyle Behaviours of Children and Adolescents During the First Two Waves of the COVID-19 Pandemic in Switzerland and Their Relation to Well-Being: An Observational Study
  62. Pediatric hospital admissions, case severity, and length of hospital stay during the first 18 months of the COVID-19 pandemic in a tertiary children’s hospital in Switzerland
  63. Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States
  64. Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort
  65. Risk of SARS-CoV-2 Acquisition in Health Care Workers According to Cumulative Patient Exposure and Preferred Mask Type
  66. Is living in a household with children associated with SARS-CoV-2 seropositivity in adults? Results from the Swiss national seroprevalence study Corona Immunitas
  67. Outcomes of etravirine-based antiretroviral treatment in treatment-experienced children and adolescents living with HIV in Europe and Thailand
  68. Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis
  69. The Corona Immunitas Digital Follow-Up eCohort to Monitor Impacts of the SARS-CoV-2 Pandemic in Switzerland: Study Protocol and First Results
  70. Safety Evaluation of a Medical Congress Held During the COVID-19 Pandemic—A Prospective Cohort
  71. Impact of respirator versus surgical masks on SARS-CoV-2 acquisition in healthcare workers: a prospective multicentre cohort
  72. Symptoms Compatible With Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection—Results of a Prospective Multicenter Cohort
  73. The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
  74. SwissPedData: Standardising hospital records for the benefit of paediatric research
  75. No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: a prospective healthcare worker study
  76. Digital SARS-CoV-2 Detection Among Hospital Employees: Participatory Surveillance Study
  77. Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19—a prospective multicenter cohort study
  78. Children living with HIV in Europe: do migrants have worse treatment outcomes?
  79. Interseasonal RSV infections in Switzerland – rapid establishment of a clinician-led national reporting system (RSV EpiCH)
  80. Decrease of condom use in heterosexual couples and its impact on pregnancy rates: the Swiss HIV Cohort Study (SHCS)
  81. Clinical data for paediatric research: the Swiss approach
  82. Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers – A multicentre cross-sectional study
  83. Cohort Profile Update: The Swiss HIV Cohort Study (SHCS)
  84. Maternal outcomes and risk factors for COVID-19 severity among pregnant women
  85. Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link
  86. Strain-Resolved Dynamics of the Lung Microbiome in Patients with Cystic Fibrosis
  87. The Effects of Corticosteroids on the Respiratory Microbiome: A Systematic Review
  88. The influence of human genetic variation on Epstein–Barr virus sequence diversity
  89. Leptospirosis Followed by Kawasaki-Like Disease: Case Report From an Adult Swiss Patient and Review of the Literature
  90. Can antibody tests accurately detect prior SARS-CoV-2 infection?
  91. Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study
  92. Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland
  93. Flattening the curve in 52 days: characterisation of the COVID-19 pandemic in the Principality of Liechtenstein – an observational study
  94. Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study
  95. Novel dual HIV maintenance therapy with nevirapine plus lamivudine retain viral suppression through 144 weeks—A proof-of-concept study
  96. Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study
  97. EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA)
  98. Swiss consensus recommendations on urinary tract infections in children
  99. Cohort-Derived Machine Learning Models for Individual Prediction of Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: A Prospective Multicenter Cohort Study
  100. Lymphocyte Subsets in HIV-Exposed Uninfected Infants: The Impact of Neonatal Postexposure Prophylaxis With Zidovudine
  101. Whole-exome sequencing for the identification of rare variants in primary immunodeficiency genes in children with sepsis - a prospective population-based cohort study
  102. Temporal Course of SARS‐CoV‐2 Antibody Positivity in Patients with COVID‐19 following the First Clinical Presentation
  103. SDHA gain-of-function engages inflammatory mitochondrial retrograde signaling via KEAP1–Nrf2
  104. CD4 recovery following antiretroviral treatment interruptions in children and adolescents with HIV infection in Europe and Thailand
  105. Nevirapine in HIV maintenance therapy – can “old drugs” survive in current HIV management?
  106. The rate of mother-to-child transmission of antiretroviral drug-resistant HIV strains is low in the Swiss Mother and Child HIV Cohort Study
  107. Burden of Streptococcus pneumoniae sepsis in children after introduction of pneumococcal conjugate vaccines - a prospective population-based cohort study
  108. Antibiotic-resistant pathogens in different patient settings and identification of surveillance gaps in Switzerland – a systematic review
  109. Birth Defects Following Exposure to Efavirenz-Based Antiretroviral Therapy at Conception/First Trimester of Pregnancy
  110. Assessment of urinary 3-indoxyl sulfate as a marker for gut microbiota diversity and abundance of Clostridiales
  111. Time-to-Positivity of Blood Cultures in Children With Sepsis
  112. Is breastfeeding an equipoise option in effectively treated HIV-infected mothers in a high-income setting?
  113. Antibiotic resistance in Swiss nursing homes: analysis of National Surveillance Data over an 11-year period between 2007 and 2017
  114. Neonatal Sepsis of Early Onset, and Hospital-Acquired and Community-Acquired Late Onset: A Prospective Population-Based Cohort Study
  115. Hand hygiene adherence in relation to influenza season during 6 consecutive years
  116. Akutes rheumatisches Fieber
  117. Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: a population-based cohort study
  118. Impact of viral multiplex real-time PCR on management of respiratory tract infection: a retrospective cohort study
  119. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details
  120. OUP accepted manuscript
  121. Heterogeneity in testing practices for infections during pregnancy: national survey across Switzerland
  122. Incidence and Outcome of Group B Streptococcal Sepsis in Infants in Switzerland
  123. Late treatment failures in cerebrospinal fluid in patients on long-term maintenance ART with ritonavir-boosted protease PI monotherapy
  124. Transmission of multidrug-resistant Mycobacterium tuberculosis is reality in Switzerland
  125. Syphilis: Diagnostik und Behandlung
  126. Primary cutaneous aspergillosis in a preterm neonate
  127. Gonorrhoe: neue Empfehlungen zu Diagnostik und Behandlung
  128. Mikrobiom – die Entdeckung eines Organs
  129. Postexpositionelle Prophylaxe (PEP) von HIV ausserhalb des Medizinalbereichs
  130. Determinants of Hepatitis A Vaccine Immunity in a Cohort of Human Immunodeficiency Virus-Infected Children Living in Switzerland
  131. To Say or Not to Say: A Qualitative Study on the Disclosure of Their Condition by Human Immunodeficiency Virus–Positive Adolescents
  132. Sudden infant death syndrome in infants born to HIV-infected and opiate-using mothers
  133. Akutes Fieber beim Kleinkind
  134. Statin-induced immunomodulatory effects on human T cells in vivo
  135. Gynecomastia and potent antiretroviral therapy
  136. Ritonavir boosted indinavir treatment as a simplified maintenance ‘mono'-therapy for HIV infection
  137. Oral valganciclovir in children: single dose pharmacokinetics in a six-year-old girl
  138. Sensitization to Human Immunodeficiency Virus in Seronegative Exposed Partners